EPB41
Basic information
Region (hg38): 1:28887091-29120046
Previous symbols: [ "EL1" ]
Links
Phenotypes
GenCC
Source:
- hereditary elliptocytosis (Supportive), mode of inheritance: AD
- elliptocytosis 1 (Strong), mode of inheritance: AD
- elliptocytosis 1 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ellipsocytosis 1 | AR | Hematologic | The recessive form is more severe, and due to anemia, individuals may require transfusions, and/or splenectomy | Hematologic | 5731934; 7255153; 6894932; 7082842; 3965051; 3995181; 3755799; 3748797; 3674005; 1430200; 16730867; 14692233; 21839655 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- EPB41-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EPB41 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 22 | ||||
missense | 62 | 69 | ||||
nonsense | 8 | |||||
start loss | 1 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 12 | 22 | ||||
Total | 4 | 12 | 70 | 28 | 17 |
Variants in EPB41
This is a list of pathogenic ClinVar variants found in the EPB41 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-28987182-C-A | Benign (Nov 11, 2018) | |||
1-28987461-G-A | Elliptocytosis 1 • EPB41-related disorder | Benign (Jan 18, 2024) | ||
1-28987470-C-G | Likely benign (Jan 01, 2023) | |||
1-28987471-G-A | Uncertain significance (Oct 11, 2022) | |||
1-28987550-C-G | Uncertain significance (Mar 10, 2022) | |||
1-28987557-A-G | Elliptocytosis 1 • EPB41-related disorder | Benign (Nov 23, 2023) | ||
1-28987609-G-A | Elliptocytosis 1 | Conflicting classifications of pathogenicity (Nov 14, 2023) | ||
1-28987657-T-C | Uncertain significance (-) | |||
1-28987689-C-G | Uncertain significance (Sep 25, 2023) | |||
1-28987692-G-A | EPB41-related disorder | Likely benign (Feb 16, 2021) | ||
1-28987700-A-G | Elliptocytosis 1 | Conflicting classifications of pathogenicity (Sep 27, 2023) | ||
1-28987790-T-A | Elliptocytosis 1 | Uncertain significance (Aug 31, 2023) | ||
1-28987852-C-T | Elliptocytosis 1 | Uncertain significance (-) | ||
1-28987863-C-T | Elliptocytosis 1 | Likely benign (Oct 17, 2021) | ||
1-28987864-C-G | Uncertain significance (May 24, 2021) | |||
1-28987909-A-T | Uncertain significance (Sep 01, 2023) | |||
1-28993376-AAGG-A | Uncertain significance (Apr 10, 2023) | |||
1-28993390-G-A | Likely benign (Aug 19, 2022) | |||
1-28993408-G-C | Uncertain significance (Sep 26, 2022) | |||
1-28993427-CT-C | Uncertain significance (Sep 09, 2022) | |||
1-28993489-A-G | Pathogenic/Likely pathogenic (Dec 12, 2019) | |||
1-28993490-T-C | Elliptocytosis 1 | Pathogenic (Jan 01, 1995) | ||
1-28993490-T-G | Elliptocytosis 1 | Pathogenic (Nov 01, 1992) | ||
1-28993496-G-A | Uncertain significance (Oct 12, 2020) | |||
1-28993500-G-A | Likely benign (Sep 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EPB41 | protein_coding | protein_coding | ENST00000343067 | 19 | 232951 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000359 | 1.00 | 125695 | 0 | 53 | 125748 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.922 | 406 | 462 | 0.879 | 0.0000252 | 5670 |
Missense in Polyphen | 210 | 267.85 | 0.78402 | 3173 | ||
Synonymous | 0.276 | 160 | 165 | 0.973 | 0.00000926 | 1625 |
Loss of Function | 4.25 | 17 | 49.1 | 0.346 | 0.00000263 | 602 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000474 | 0.000474 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000323 | 0.000323 |
European (Non-Finnish) | 0.000167 | 0.000167 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Protein 4.1 is a major structural element of the erythrocyte membrane skeleton. It plays a key role in regulating membrane physical properties of mechanical stability and deformability by stabilizing spectrin-actin interaction. Recruits DLG1 to membranes. Required for dynein-dynactin complex and NUMA1 recruitment at the mitotic cell cortex during anaphase (PubMed:23870127). {ECO:0000269|PubMed:23870127}.;
- Disease
- DISEASE: Elliptocytosis 1 (EL1) [MIM:611804]: A Rhesus-linked form of hereditary elliptocytosis, a genetically heterogeneous, autosomal dominant hematologic disorder. It is characterized by variable hemolytic anemia and elliptical or oval red cell shape. {ECO:0000269|PubMed:3467321}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Splicing factor NOVA regulated synaptic proteins;Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses;Syndecan-2-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.359
Intolerance Scores
- loftool
- 0.0367
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.19
Haploinsufficiency Scores
- pHI
- 0.757
- hipred
- Y
- hipred_score
- 0.744
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.945
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Epb41
- Phenotype
- renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- epb41b
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- increased fragility
Gene ontology
- Biological process
- cell cycle;regulation of cell shape;actin cytoskeleton organization;cortical actin cytoskeleton organization;actomyosin structure organization;positive regulation of protein binding;cell division;protein-containing complex assembly;positive regulation of protein localization to cell cortex
- Cellular component
- nucleus;cytosol;plasma membrane;cytoplasmic side of plasma membrane;postsynaptic density;spectrin-associated cytoskeleton;cell junction;cortical cytoskeleton;protein-containing complex;cell cortex region
- Molecular function
- actin binding;structural constituent of cytoskeleton;protein binding;calmodulin binding;1-phosphatidylinositol binding;protein C-terminus binding;spectrin binding;protein N-terminus binding;phosphoprotein binding